Arthritis Monoclonal Antibodies Market Growth Trajectory Through 2024-2033

1
Arthritis Monoclonal Antibodies Global Market
Report 2024
Market Size, Trends and Global Forecast 2024-2033
2
Arthritis Monoclonal Antibodies Market Segments
The Business Research Company segments its
Arthritis Monoclonal Antibodies market report as
Remicade, Humira, Enbrel, Rituxan, Orencia,
Actemra, Simponi, Cimzia, Remsima
By Drug
By Application
Rheumatoid Arthritis, Osteoarthritis, Psoriatic
Arthritis, Ankylosing Spondylitis, Fibromyalgia
By End-Use
Hospitals, Research Institutes, Other End-Users
By Industry
3
Market Statistics
The arthritis monoclonal antibodies market size
has grown strongly in recent years. It will grow
from 58.09 billion in 2023 to 62.29 billion in
2024 at a compound annual growth rate (CAGR) of
7.2. The arthritis monoclonal antibodies market
size is expected to see strongly grown in the
next few years. It will grow to 83.76 billion in
2028 at a compound annual growth rate (CAGR) of
7.7.
Click Here To Get A Sample Report
4
Key Market Drivers And Trends
Drivers
The increasing prevalence of arthritis globally
has contributed to the growth of the arthritis
monoclonal antibody market.
Trends
The rising approvals for personalized medicines
are expected to propel the arthritis monoclonal
antibody market going forward.
Region
North America was the largest region in the
control valve market. The regions covered in the
global control valve market report are
Asia-Pacific, Western Europe, Eastern Europe,
North America, South America, Middle East and
Africa.
5
Key Market Players

• Major players in the Arthritis Monoclonal
  Antibodies market are
• Johnson Johnson
• Hoffmann-La Roche Ltd.
• Novartis AG
• Pfizer Inc
• AbbVie Inc.
• And more.

6
5 Reasons Why TBRC Is The Solution You Need

1. Measure the impact of high global inflation on
   market growth
2. Outperform competitors using forecast data and
   the drivers and trends shaping the market
3. Get a compreArthritis Monoclonal Antibodiessive
   market sizing report with a truly global
   perspective covering 60 geographies from The
   Business Research Company, with data from 2017 to
   2023 and forecasts up to 2032.
4. Assess the Russia-Ukraine wars impact on
   commodity supply and its direct and indirect
   impact on all the markets
5. Benchmark performance against key competitors.

7
Americas The Business Research Company, 1295 N
Providence Rd, Arthritis Monoclonal Antibodies,
PA 19063, USA ? 1 3156230293
Get In Touch
Europe The Business Research Company 47 Anchorage
Point, 42 Cuba Street, Canary Wharf, London,
England, E14 8NE ? 44 207 1930 708
How ever you want to grow and expand, The
Business Research Company can help as we provide
research consulting solutions for businesses,
government agencies consultancies, and market
research companies.
Asia The Business Research Company, 1st Floor,
Anshu Colors Building, Road Number 1, Park View
Enclave, Jubilee Hills, Hyderabad (India),
500033 ? 91 8897263534
info_at_tbrc.info
8
Your Growth Insights Partner